Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours

por Tovey, S M, Brown, S, Doughty, J C, Mallon, E A, Cooke, T G, Edwards, J
Publicado 2009

Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?

por Neale, R E, Doecke, J D, Pandeya, N, Sadhegi, S, Green, A C, Webb, P M, Whiteman, D C
Publicado 2009

CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts

por Marangoni, E, Lecomte, N, Durand, L, de Pinieux, G, Decaudin, D, Chomienne, C, Smadja-Joffe, F, Poupon, M-F
Publicado 2009

Methodological approaches in application of synthetic lethality screening towards anticancer therapy

por Canaani, D
Publicado 2009

Early diagnosis of oesophageal cancer

por Bird-Lieberman, E L, Fitzgerald, R C
Publicado 2009

Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences

por Chen, Y-Y, You, S-L, Chen, C-A, Shih, L-Y, Koong, S-L, Chao, K-Y, Hsiao, M-L, Hsieh, C-Y, Chen, C-J
Publicado 2009

Mitochondrial dysfunction resulting from loss of cytochrome c impairs radiation-induced bystander effect

por Yang, G, Wu, L, Chen, S, Zhu, L, Huang, P, Tong, L, Zhao, Y, Zhao, G, Wang, J, Mei, T, Xu, A, Wang, Y
Publicado 2009

Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?

por Maraveyas, A, Johnson, M
Publicado 2009

Societal preference values for advanced melanoma health states in the United Kingdom and Australia

por Beusterien, K M, Szabo, S M, Kotapati, S, Mukherjee, J, Hoos, A, Hersey, P, Middleton, M R, Levy, A R
Publicado 2009

EBV-associated gastric carcinoma in high- and low-incidence areas for nasopharyngeal carcinoma

por Boysen, T, Mohammadi, M, Melbye, M, Hamilton-Dutoit, S, Vainer, B, Hansen, A V, Wohlfahrt, J, Friborg, J
Publicado 2009

The impact of BMI on subgroups of uterine cancer

por Lindemann, K, Vatten, L J, Ellstrøm-Engh, M, Eskild, A
Publicado 2009

Phase II study of docetaxel in patients with relapsed or refractory malignant lymphoma

por Zekri, J M, Hough, R E, Davies, J M, Molife, R, Hancock, B W, Lorigan, P C
Publicado 2003

Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure

por Tonetti, D A, Morrow, M, Kidwai, N, Gupta, A, Badve, S
Publicado 2003

ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus

por Ries, S, Korn, W M
Publicado 2002

Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups

por Moorman, A V, Roman, E, Cartwright, R A, Morgan, G J
Publicado 2002

Generation of dendritic cell-based vaccines for cancer therapy

por Reinhard, G, Märten, A, Kiske, S M, Feil, F, Bieber, T, Schmidt-Wolf, I G H
Publicado 2002

Methylation pattern of CDH13 gene in digestive tract cancers

por Hibi, K, Kodera, Y, Ito, K, Akiyama, S, Nakao, A
Publicado 2004

Is there a role for chemotherapy in prostate cancer?

por Canil, C M, Tannock, I F
Publicado 2004

Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors

por Kelly, S, Wheatley, D
Publicado 2009

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

por Depierre, A, Lagrange, J L, Theobald, S, Astoul, P, Baldeyrou, P, Bardet, E, Bazelly, B, Bréchot, J M, Breton, J L, Douillard, J Y, Grivaux, M, Jacoulet, P, Khalil, A, Lemarié, E, Martinet, Y, Massard, G, Milleron, B, Molina, T, Moro-Sibilot, D, Paesmans, M, Pujol, J L, Quoix, E, Ranfaing, E, Rivière, A, Sancho-Garnier, H, Souquet, P J, Spaeth, D, Stœbner-Delbarre, A, Thiberville, L, Touboul, E, Vaylet, F, Vergnon, J M, Westeel, V
Publicado 2003